BMJ Open Diabetes Research & Care
is an open access diabetes journal from the ADA and BMJ that strives to publish innovative studies on diabetes in all disciplines and therapeutic areas as quickly and transparently as possible.
Impact Factor: 4.186
Citescore: 4.2
All metrics >>
Latest Articles
Pathophysiology/complications:
Glomerular filtration rate in patients with type 2 diabetes mellitus: is serum isthmin-1 level a possible link?28 August 2023
Epidemiology/Health services research:
Implementation of flash glucose monitoring in four pediatric diabetes clinics: controlled before and after study to produce real-world evidence of patient benefit28 August 2023
Obesity studies:
Association of body indices and risk of mortality in patients with type 2 diabetes22 August 2023
Epidemiology/Health services research:
Socioeconomic status, maternal risk factors, and gestational diabetes mellitus across reproductive years: a Finnish register-based study16 August 2023
Epidemiology/Health services research:
Diabetic Retinopathy Screening at the Point of Care (DR SPOC): detecting undiagnosed and vision-threatening retinopathy by integrating portable technologies within existing services2 August 2023
Most Read Articles
Cardiovascular and metabolic risk:
Use of oral diabetes medications and the risk of incident dementia in US veterans aged ≥60 years with type 2 diabetes11 October 2022
Cardiovascular and metabolic risk:
How sweet is your love? Disentangling the role of marital status and quality on average glycemic levels among adults 50 years and older in the English Longitudinal Study of Ageing6 February 2023
Emerging technologies, pharmacology and therapeutics:
Add-on imeglimin versus metformin dose escalation regarding glycemic control in patients with type 2 diabetes treated with a dipeptidyl peptidase-4 inhibitor plus low-dose metformin: study protocol for a multicenter, prospective, randomized, open-label, …15 November 2022
Epidemiology/Health services research:
Prevalence of diabetes and pre-diabetes in Sri Lanka: a new global hotspot–estimates from the Sri Lanka Health and Ageing Survey 2018/201915 February 2023
Cardiovascular and Metabolic Risk
Cardiovascular and metabolic risk:
MDRD is the eGFR equation most strongly associated with 4-year mortality among patients with diabetes in Colombia20 July 2023
Cardiovascular and metabolic risk:
Efficacy and safety of luseogliflozin in Caucasian patients with type 2 diabetes: results from a phase III, randomized, placebo-controlled, clinical trial16 June 2023
Cardiovascular and metabolic risk:
Cardiorenal protective effects of canagliflozin in CREDENCE according to glucose lowering13 June 2023
Cardiovascular and metabolic risk:
Long-term effect of intensive lifestyle intervention on cardiometabolic risk factors and microvascular complications in patients with diabetes in real-world clinical practice: a 10-year longitudinal study22 May 2023
Cardiovascular and metabolic risk:
Trends in glycemic, blood pressure, and lipid control in adults with diabetes in Switzerland: the CoLaus|PsyCoLaus Study15 May 2023